Travere Therapeutics (TVTX) Total Debt (2016 - 2025)
Historic Total Debt for Travere Therapeutics (TVTX) over the last 13 years, with Q2 2025 value amounting to $68.8 million.
- Travere Therapeutics' Total Debt changed N/A to $68.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $68.8 million, marking a year-over-year change of. This contributed to the annual value of $68.7 million for FY2024, which is N/A changed from last year.
- Per Travere Therapeutics' latest filing, its Total Debt stood at $68.8 million for Q2 2025.
- Over the past 5 years, Travere Therapeutics' Total Debt peaked at $68.8 million during Q2 2025, and registered a low of $6.9 million during Q1 2023.
- For the 5-year period, Travere Therapeutics' Total Debt averaged around $29.6 million, with its median value being $7.4 million (2021).
- Its Total Debt has fluctuated over the past 5 years, first crashed by 5747.13% in 2021, then plummeted by 540.54% in 2022.
- Travere Therapeutics' Total Debt (Quarter) stood at $7.4 million in 2021, then decreased by 5.41% to $7.0 million in 2022, then decreased by 1.43% to $6.9 million in 2023, then surged by 895.33% to $68.7 million in 2024, then increased by 0.23% to $68.8 million in 2025.
- Its Total Debt stands at $68.8 million for Q2 2025, versus $68.8 million for Q1 2025 and $68.7 million for Q4 2024.